Company Description
OmniAb (NASDAQ: OABIW) is classified in the Services-commercial Physical & Biological Research sector.
OABIW has declined 74.9% over the past year. Shares last traded at $0.0451.
For FY2025, OmniAb reported revenue of $18.7M with net income of -$64.8M and diluted earnings per share of $-0.57. The company operates at a net profit margin of -347.0%.
This page collects what Stock Titan holds for OABIW, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
OmniAb (OABIW) stock last closed at $0.0451. Over the past 12 months, the stock has lost 74.9%.
OABIW Rankings
Latest News
SEC Filings
OmniAb has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form 3, 1 Form 4, 1 Form 10-Q. The most recent filing was submitted on August 6, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all OABIW SEC filings →
Financial Highlights
OmniAb generated $18.7M in revenue in FY2025, operating income reached -$69.0M (-369.5% operating margin), and net income was -$64.8M, reflecting a -347.0% net profit margin. Diluted earnings per share stood at $-0.57. The company generated -$36.5M in operating cash flow. With a current ratio of 4.02, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in OmniAb (OABIW) currently stands at 9.8 thousand shares, down 4.7% from the previous reporting period. Since August 2025, short interest has decreased by 34.4%. With 141.7 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for OmniAb (OABIW) currently stands at 141.7 days, up 1153.2% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 4944.1% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 319.6 days.
OABIW Company Profile & Sector Positioning
OmniAb (OABIW) operates in the Services-commercial Physical & Biological Research sector and is listed on the NASDAQ.